
Overview
Robin Hardie is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Hardie has been practicing medicine for over 28 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Paget Disease of the Breast, Monoclonal Gammopathy of Undetermined Significance (MGUS), Familial Colorectal Cancer, and Colorectal Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- MEDICARE PDP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
40 Duke Medicine Cir, Durham, NC 27710
University Of North Carolina At Chapel Hill
Joshua Zeidner is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Zeidner is rated as an Elite provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Zeidner is currently accepting new patients.
Duke Blood Cancer Center
I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians. Dr. Erba is rated as an Elite provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.
UT MD Anderson Cancer Center
Guilin Tang is a Hematologist in Cary, North Carolina. Dr. Tang is rated as an Elite provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Leukemia, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Mantle Cell Lymphoma (MCL), and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Hardie isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Hardie isDistinguished. Learn about Breast Cancer.
- Chronic Lymphocytic Leukemia (CLL)Dr. Hardie isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Colorectal CancerDr. Hardie isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Hardie isDistinguished. Learn about Familial Colorectal Cancer.
- Inflammatory Breast CancerDr. Hardie isDistinguished. Learn about Inflammatory Breast Cancer.
- Advanced
- Adult Immune ThrombocytopeniaDr. Hardie isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Hardie isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- B-Cell LymphomaDr. Hardie isAdvanced. Learn about B-Cell Lymphoma.
- Chromophobe Renal Cell CarcinomaDr. Hardie isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Hardie isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Experienced
- Acute Mountain SicknessDr. Hardie isExperienced. Learn about Acute Mountain Sickness.
- AgranulocytosisDr. Hardie isExperienced. Learn about Agranulocytosis.
- Alveolar Soft Part SarcomaDr. Hardie isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Anal CancerDr. Hardie isExperienced. Learn about Anal Cancer.
- AnemiaDr. Hardie isExperienced. Learn about Anemia.
- Bladder CancerDr. Hardie isExperienced. Learn about Bladder Cancer.
